Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06743269 · ClinicalTrials.gov registry record · NA
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
A NA study of Menopause and Hot Flashes, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06743269: Recruiting NA study of Menopause and Hot Flashes, sponsored by Mayo Clinic.
NCT06743269 is a NA study of Menopause and Hot Flashes that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06743269, a NA study of Menopause and Hot Flashes, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to understand how training the muscles used for breathing (inhalation) affects menopausal hot flashes, sympathetic nerve activity and sleep.
Primary Outcome
Measured in millimeters of mercury (mm Hg)
Conditions Studied
Interventions
- BEHAVIORAL High-Resistance Inspiratory Muscle Strength Training
- BEHAVIORAL Low-Resistance Inspiratory Muscle Strength Training
- DEVICE POWERbreathe K3 device
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06743269 shows while recruiting
NCT06743269 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 9,394-participant average among 54 other Menopause trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Menopause appearing as the primary indexed condition, and to 3 interventions - of which High-Resistance Inspiratory Muscle Strength Training is the first listed.
NCT06743269 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06743269 about?
NCT06743269 is a clinical study titled "Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training". The purpose of this research is to understand how training the muscles used for breathing (inhalation) affects menopausal hot flashes, sympathetic nerve activity and sleep.
What is the current status of trial NCT06743269?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-27. Estimated completion is 2027-01.
What conditions does trial NCT06743269 study?
This clinical trial studies the following conditions: Menopause, Hot Flashes, Blood Pressure Regulation.
What interventions are being tested in trial NCT06743269?
The interventions under investigation include: High-Resistance Inspiratory Muscle Strength Training (BEHAVIORAL), Low-Resistance Inspiratory Muscle Strength Training (BEHAVIORAL), POWERbreathe K3 device (DEVICE).
Who is sponsoring clinical trial NCT06743269?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06743269 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06743269's enrollment target sits among peer trials
30 41st of 54 higher than 11 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
-
Following Lipectomy to Understand Adipose Tissue Re-accumulation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI